Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
Congenital myasthenic syndromes are a group of inherited disorders characterized by defective neuromuscular transmission and fatigable muscle weakness. Causative mutations have been identified in over 30 genes, including DOK7, a gene encoding a post-synaptic protein crucial in the formation and stab...
Main Authors: | Cossins, J, Kozma, I, Canzonetta, C, Hawkins, A, Beeson, D, Sepulveda, P, Dong, YY |
---|---|
格式: | Journal article |
语言: | English |
出版: |
Oxford University Press
2025
|
相似书籍
-
Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
由: Hamuro, J, et al.
出版: (2008) -
Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
由: Palace, J
出版: (2010) -
EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
由: Lashley, D, et al.
出版: (2009) -
Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7
由: Yu-Ting Huang, et al.
出版: (2023-09-01) -
DOK7 congenital myasthenic syndrome.
由: Palace, J
出版: (2012)